Literature DB >> 24046145

Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Yong He1, Cheng Huang, Bao-Ming Wu, Jun Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24046145     DOI： 10.1007/s00296-013-2868-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  11 in total

1.  Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?

Authors:  S J Curnow; K Pryce; N Modi; B Knight; E M Graham; J E Stewart; F Fortune; M R Stanford; P I Murray; G R Wallace
Journal:  Immunol Lett       Date:  2008-08-13       Impact factor: 3.685

2.  The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet's disease.

Authors:  Jung-Yoon Choe; Hwajeong Lee; Sang Gyung Kim; Min Ji Kim; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2013-02-17       Impact factor: 2.631

3.  Intraocular cytokine environment in active Behçet uveitis.

Authors:  Jae Kyoun Ahn; Hyeong Gon Yu; Hum Chung; Yeoung Geol Park
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

4.  The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.

Authors:  M Orchardson; J A Gracie; B P Leung; H Guan; W Niedbala; G K Paterson; I B McInnes; F Y Liew
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers.

Authors:  Melike Melikoglu; Serpil Uysal; James G Krueger; Gilla Kaplan; Feride Gogus; Hasan Yazici; Stephen Oliver
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

6.  Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Dustan Kangave; Saleh S Al-Obeidan; Ghislain Opdenakker; Karel Geboes; Jo Van Damme
Journal:  Clin Immunol       Date:  2011-01-31       Impact factor: 3.969

7.  Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.

Authors:  K Hamzaoui; A Hamzaoui; I Ghorbel; M Khanfir; H Houman
Journal:  Scand J Immunol       Date:  2006-12       Impact factor: 3.487

8.  Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.

Authors:  Antonio Clemente; Ana Cambra; Iván Munoz-Saá; Catalina Crespí; Lucio Pallarés; Antonio Juan; Núria Matamoros; Maria Rosa Julià
Journal:  Immunol Lett       Date:  2010-02-16       Impact factor: 3.685

9.  Therapeutic potency of Poly I:C in HSV-induced inflammation through up-regulation of IL-15 receptor alpha.

Authors:  Juyoung Choi; Eun-So Lee; Bunsoon Choi; Seonghyang Sohn
Journal:  Immunobiology       Date:  2013-04-05       Impact factor: 3.144

Review 10.  Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.

Authors:  Spencer W Stonier; Kimberly S Schluns
Journal:  Immunol Lett       Date:  2009-10-07       Impact factor: 3.685
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.